TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

(Post-pandemic Era)-Global Vaccines & Vaccination Market Segment Research Report 2022

(Post-pandemic Era)-Global Vaccines & Vaccination Market Segment Research Report 2022

  • Category:Life Sciences
  • Published on : 30 August 2022
  • Pages :117
  • Formats:
  • Report Code:SMR-7306985
OfferClick for best price

Best Price: $2280

Postpemic Era Vaccines & Vaccination Market Size, Share 2022


Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Global Vaccines & Vaccination Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Vaccines & Vaccination industry at home and abroad, estimate the overall market scale of the Vaccines & Vaccination industry and the market share of major countries, Vaccines & Vaccination industry, and study and judge the downstream market demand of Vaccines & Vaccination through systematic research, Analyze the competition pattern of Vaccines & Vaccination, so as to help solve the pain points of various stakeholders in Vaccines & Vaccination industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Vaccines & Vaccination Market by XYZResearch Include

USA

Europe

China

Japan

India

Korea

Southeast Asia

Competitive Analysis; Who are the Major Players in Vaccines & Vaccination Market?

Abbott

AstraZeneca

Bavarian Nordic

Novartis

Bharat Biotech

Bio-Med

CSL

Emergent BioSolutions

GSK

Johnson & Johnson

Pfizer

Merck

Sanofi

Major Type of Vaccines & Vaccination Covered in XYZResearch report:

Subunit vaccines

Live attenuated vaccines

Conjugate vaccines

Inactivated vaccines

Recombinant vector vaccines

Toxoid vaccines

Synthetic vaccines

Dendritic cell vaccines

Application Segments Covered in XYZResearch Market

Baby Vaccine

Adult Special Vaccine

Other

For any other requirements, please feel free to contact us and we will provide you customized report.

Report Attributes Report Details
Report Title (Post-pandemic Era)-Global Vaccines & Vaccination Market Segment Research Report 2022
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 117 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

Table of Contents

Global Vaccines & Vaccination Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Vaccines & Vaccination Market by Value
2.2.1 Global Vaccines & Vaccination Revenue by Type
2.2.2 Global Vaccines & Vaccination Market by Value (%)
2.3 Global Vaccines & Vaccination Market by Production
2.3.1 Global Vaccines & Vaccination Production by Type
2.3.2 Global Vaccines & Vaccination Market by Production (%)

3. The Major Driver of Vaccines & Vaccination Industry
3.1 Historical & Forecast Global Vaccines & Vaccination Demand
3.2 Largest Application for Vaccines & Vaccination (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Vaccines & Vaccination Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Vaccines & Vaccination Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Vaccines & Vaccination Production, Demand (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Vaccines & Vaccination Production, Demand (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Vaccines & Vaccination Production, Demand (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Vaccines & Vaccination Production, Demand (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Vaccines & Vaccination Production, Demand (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Vaccines & Vaccination Production, Demand (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Vaccines & Vaccination Production, Demand (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Vaccines & Vaccination Average Price Trend
12.1 Market Price for Each Type of Vaccines & Vaccination in US (2018-2022)
12.2 Market Price for Each Type of Vaccines & Vaccination in Europe (2018-2022)
12.3 Market Price for Each Type of Vaccines & Vaccination in China (2018-2022)
12.4 Market Price for Each Type of Vaccines & Vaccination in Japan (2018-2022)
12.5 Market Price for Each Type of Vaccines & Vaccination in India (2018-2022)
12.6 Market Price for Each Type of Vaccines & Vaccination in Korea (2018-2022)
12.7 Market Price for Each Type of Vaccines & Vaccination in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Vaccines & Vaccination Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Vaccines & Vaccination

14. Vaccines & Vaccination Competitive Landscape
14.1 Abbott
14.1.1 Abbott Company Profiles
14.1.2 Abbott Product Introduction
14.1.3 Abbott Vaccines & Vaccination Sales, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 AstraZeneca
14.2.1 AstraZeneca Company Profiles
14.2.2 AstraZeneca Product Introduction
14.2.3 AstraZeneca Vaccines & Vaccination Sales, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Bavarian Nordic
14.3.1 Bavarian Nordic Company Profiles
14.3.2 Bavarian Nordic Product Introduction
14.3.3 Bavarian Nordic Vaccines & Vaccination Sales, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Novartis
14.4.1 Novartis Company Profiles
14.4.2 Novartis Product Introduction
14.4.3 Novartis Vaccines & Vaccination Sales, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Bharat Biotech
14.5.1 Bharat Biotech Company Profiles
14.5.2 Bharat Biotech Product Introduction
14.5.3 Bharat Biotech Vaccines & Vaccination Sales, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Bio-Med
14.6.1 Bio-Med Company Profiles
14.6.2 Bio-Med Product Introduction
14.6.3 Bio-Med Vaccines & Vaccination Sales, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 CSL
14.7.1 CSL Company Profiles
14.7.2 CSL Product Introduction
14.7.3 CSL Vaccines & Vaccination Sales, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Emergent BioSolutions
14.8.1 Emergent BioSolutions Company Profiles
14.8.2 Emergent BioSolutions Product Introduction
14.8.3 Emergent BioSolutions Vaccines & Vaccination Sales, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 GSK
14.9.1 GSK Company Profiles
14.9.2 GSK Product Introduction
14.9.3 GSK Vaccines & Vaccination Sales, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Johnson & Johnson
14.10.1 Johnson & Johnson Company Profiles
14.10.2 Johnson & Johnson Product Introduction
14.10.3 Johnson & Johnson Vaccines & Vaccination Sales, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Pfizer
14.12 Merck
14.13 Sanofi
15. Conclusion
16. Methodology and Data Source


LIST OF TABLES & FIGURES

List of Tables and Figures

Figure 1. Total Demand by Application of Vaccines & Vaccination Industry (Volume)
Figure 2. Vaccines & Vaccination Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Vaccines & Vaccination Revenue in 2022
Figure 5. US Vaccines & Vaccination Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Vaccines & Vaccination Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Vaccines & Vaccination Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Vaccines & Vaccination Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Vaccines & Vaccination Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Vaccines & Vaccination Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Vaccines & Vaccination Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Vaccines & Vaccination Revenue, by Type (Million USD) (2018-2028)
Table 4. Vaccines & Vaccination Production, by Type (K Unit) (2018-2028)
Table 5. Vaccines & Vaccination Demand (K Unit) by Application (2018-2028)
Table 6. Vaccines & Vaccination Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Vaccines & Vaccination Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Vaccines & Vaccination Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Vaccines & Vaccination Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Vaccines & Vaccination Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Vaccines & Vaccination Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Vaccines & Vaccination Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Vaccines & Vaccination Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Vaccines & Vaccination Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Vaccines & Vaccination in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Vaccines & Vaccination in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Vaccines & Vaccination in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Vaccines & Vaccination in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Vaccines & Vaccination in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Vaccines & Vaccination in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Vaccines & Vaccination in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Abbott Profiles
Table 61. Abbott Vaccines & Vaccination Product Introduction
Table 62. Abbott Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Abbott Strategic initiatives
Table 64. AstraZeneca Profiles
Table 65. AstraZeneca Vaccines & Vaccination Product Introduction
Table 66. AstraZeneca Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. AstraZeneca Strategic initiatives
Table 68. Bavarian Nordic Profiles
Table 69. Bavarian Nordic Vaccines & Vaccination Product Introduction
Table 70. Bavarian Nordic Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Bavarian Nordic Strategic initiatives
Table 72. Novartis Profiles
Table 73. Novartis Vaccines & Vaccination Product Introduction
Table 74. Novartis Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Novartis Strategic initiatives
Table 76. Bharat Biotech Profiles
Table 77. Bharat Biotech Vaccines & Vaccination Product Introduction
Table 78. Bharat Biotech Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Bharat Biotech Strategic initiatives
Table 80. Bio-Med Profiles
Table 81. Bio-Med Vaccines & Vaccination Product Introduction
Table 82. Bio-Med Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Bio-Med Strategic initiatives
Table 84. CSL Profiles
Table 85. CSL Vaccines & Vaccination Product Introduction
Table 86. CSL Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. CSL Strategic initiatives
Table 88. Emergent BioSolutions Profiles
Table 89. Emergent BioSolutions Vaccines & Vaccination Product Introduction
Table 90. Emergent BioSolutions Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Emergent BioSolutions Strategic initiatives
Table 92. GSK Profiles
Table 93. GSK Vaccines & Vaccination Product Introduction
Table 94. GSK Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. GSK Strategic initiatives
Table 97. Johnson & Johnson Profiles
Table 98. Johnson & Johnson Vaccines & Vaccination Product Introduction
Table 99. Johnson & Johnson Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Johnson & Johnson Strategic initiatives
Table 101. Pfizer Profiles
Table 102. Pfizer Vaccines & Vaccination Product Introduction
Table 103. Pfizer Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. Pfizer Strategic initiatives
Table 105. Merck Profiles
Table 106. Merck Vaccines & Vaccination Product Introduction
Table 107. Merck Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. Merck Strategic initiatives
Table 109. Sanofi Profiles
Table 110. Sanofi Vaccines & Vaccination Product Introduction
Table 111. Sanofi Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 112. Sanofi Strategic initiatives

REPORT PURCHASE OPTIONS

USD Single User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount